Differential regulation of hypoxia-inducible factor-1 through receptor tyrosine kinase transactivation in vascular smooth muscle cells

Endocrinology

Volumn 148, Issue 8, 2007, Pages 4023-4031

  Lauzier, Marie Claude ^a   Pagé, Elisabeth L ^a   Michaud, Maude D ^a   Richard, Darren E ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1; PHOSPHATIDYLINOSITOL 3 KINASE; TYROSINE KINASE RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; FREQUENCY MODULATION; IMMUNOPRECIPITATION; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STIMULATION; TRANSACTIVATION; TRANSLATION INITIATION; VASCULAR SMOOTH MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; CELLS, CULTURED; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, IGF TYPE 1; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; VASOCONSTRICTOR AGENTS;

EID: 34547136942     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0285     Document Type: Article

References (55)

1. Semenza GL 2003 Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721-732
2. 2 tension. Proc Natl Acad Sci USA 92:5510-5514
3. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95:7987-7992
4. Salceda S, Caro J 1997 Hypoxia-inducible factor 1α(HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272:22642-22647
5. 2 sensing. Science 292:464-468
6. 2-regulated prolyl hydroxylation. Science 292:468-472
7. Schofield CJ, Ratcliffe PJ 2004 Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5:343-354
8. Richard DE, Berra E, Gothie E, Roux D, Pouyssegur J 1999 p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1. J Biol Chem 274:32631-32637
9. Sang N, Stiehl DP, Bohensky J, Leshchinsky I, Srinivas V, Caro J 2003 MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. J Biol Chem 278:14013-14019
10. Mylonis I, Chachami G, Samiotaki M, Panayotou G, Paraskeva E, Kalousi A, Georgatsou E, Bonanou S, Simos G 2006 Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxiainducible factor-1α. J Biol Chem 281:33095-33106
11. Richard DE, Berra E, Pouyssegur J 2000 Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells. J Biol Chem 275:26765-26771
12. Gorlach A, Diebold I, Schini-Kerth VB, Berchner-Pfannschmidt U, Roth U, Brandes RP, Kietzmann T, Busse R 2001 Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase. Circ Res 89:47-54
13. Page EL, Robitaille GA, Pouyssegur J, Richard DE 2002 Induction of hypoxia-inducible factor-1α by transcriptional and translational mechanisms. J Biol Chem 277:48403-48409
14. Fischer OM, Hart S, Gschwind A, Ullrich A 2003 EGFR signal transactivation in cancer cells. Biochem Soc Trans 31:1203-1208
15. Waters C, Pyne S, Pyne NJ 2004 The role of G-protein coupled receptors and associated proteins in receptor tyrosine kinase signal transduction. Semin Cell Dev Biol 15:309-323
16. Wetzker R, Bohmer FD 2003 Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat Rev Mol Cell Biol 4:651-657
17. Eguchi S, Inagami T 2000 Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase. Regul Pept 91:13-20
18. Kalmes A, Vesti BR, Daum G, Abraham JA, Clowes AW 2000 Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparinbinding EGF-like growth factor. Circ Res 87:92-98
19. Zahradka P, Litchie B, Storie B, Helwer G 2004 Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase. Endocrinology 145:2978-2987
20. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL 2002 Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 277:38205-38211
21. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons JW, Semenza GL 2000 Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60:1541-1545
22. Owens GK, Loeb A, Gordon D, Thompson MM 1986 Expression of smooth muscle-specific α-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J Cell Biol 102:343-352
23. Tian H, McKnight SL, Russell DW 1997 Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 11:72-82
24. Semenza GL, Wang GL 1992 A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12:5447-5454
25. Eguchi S, Iwasaki H, Ueno H, Frank GD, Motley ED, Eguchi K, Marumo F, Hirata Y, Inagami T 1999 Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt. J Biol Chem 274:36843-36851
26. Parrizas M, Gazit A, Levitzki A, Wertheimer E, LeRoith D 1997 Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology 138:1427-1433
27. Levitzki A, Gazit A 1995 Tyrosine kinase inhibition: an approach to drug development. Science 267:1782-1788
28. Sodhi A, Montaner S, Patel V, Zohar M, Bais C, Mesri EA, Gutkind JS 2000 The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1α. Cancer Res 60:4873-4880
29. Conrad PW, Freeman TL, Beitner-Johnson D, Millhorn DE 1999 EPAS1 trans-activation during hypoxia requires p42/p44 MAPK. J Biol Chem 274: 33709-33713
30. Yamanaka Y, Hayashi K, Komurasaki T, Morimoto S, Ogihara T, Sobue K 2001 EGF family ligand-dependent phenotypic modulation of smooth muscle cells through EGF receptor. Biochem Biophys Res Commun 281:373-377
31. Servant MJ, Giasson E, Meloche S 1996 Inhibition of growth factor-induced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells. J Biol Chem 271:16047-16052
32. Murasawa S, Mori Y, Nozawa Y, Gotoh N, Shibuya M, Masaki H, Maruyama K, Tsutsumi Y, Moriguchi Y, Shibazaki Y, Tanaka Y, Iwasaka T, Inada M, Matsubara H 1998 Angiotensin II type 1 receptor-induced extracellular signal-regulated protein kinase activation is mediated by Ca2+/calmodulin- dependent transactivation of epidermal growth factor receptor. Circ Res 82:1338-1348
33. Moriguchi Y, Matsubara H, Mori Y, Murasawa S, Masaki H, Maruyama K, Tsutsumi Y, Shibasaki Y, Tanaka Y, Nakajima T, Oda K, Iwasaka T 1999 Angiotensin II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-β synthesis via transcriptional and posttranscriptional mechanisms. Circ Res 84:1073-1084
34. Ushio-Fukai M, Griendling KK, Becker PL, Hilenski L, Halleran S, Alexander RW 2001 Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21:489-495
35. Bokemeyer D, Schmitz U, Kramer HJ 2000 Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor. Kidney Int 58:549-558
36. Spinella F, Rosano L, Elia G, Di Castro V, Natali PG, Bagnato A 2004 Endothelin-1 stimulates cyclooxygenase-2 expression in ovarian cancer cells through multiple signaling pathways: evidence for involvement of transactivation of the epidermal growth factor receptor. J Cardiovasc Pharmacol 44:S140-S143
37. Shah BH, Catt KJ 2004 Matrix metalloproteinase-dependent EGF receptor activation in hypertension and left ventricular hypertrophy. Trends Endocrinol Metab 15:241-243
38. Iwasaki H, Eguchi S, Ueno H, Marumo F, Hirata Y 1999 Endothelin-mediated vascular growth requires p42/p44 mitogen-activated protein kinase and p70 S6 kinase cascades via transactivation of epidermal growth factor receptor. Endocrinology 140:4659-4668
39. Kanda Y, Mizuno K, Kuroki Y, Watanabe Y 2001 Thrombin-induced p38 mitogen-activated protein kinase activation is mediated by epidermal growth factor receptor transactivation pathway. Br J Pharmacol 132:1657-1664
40. Rao GN, Delafontaine P, Runge MS 1995 Thrombin stimulates phosphorylation of insulin-like growth factor-1 receptor, insulin receptor substrate-1, and phospholipase C-1 in rat aortic smooth muscle cells. J Biol Chem 270:27871-27875
41. Touyz RM, Cruzado M, Tabet F, Yao G, Salomon S, Schiffrin EL 2003 Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation. Can J Physiol Pharmacol 81:159-167
42. Saward L, Zahradka P 1997 Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ Res 81:249-257
43. Voisin L, Foisy S, Giasson E, Lambert C, Moreau P, Meloche S 2002 EGF receptor transactivation is obligatory for protein synthesis stimulation by G protein-coupled receptors. Am J Physiol Cell Physiol 283:C446-C455
44. Azar ZM, Mehdi MZ, Srivastava AK 2006 Activation of insulin-like growth factor type-1 receptor is required for H2O2-induced PKB phosphorylation in vascular smooth muscle cells. Can J Physiol Pharmacol 84:777-786
45. Lee SR, Kwon KS, Kim SR, Rhee SG 1998 Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem 273:15366-15372
46. Meng TC, Fukada T, Tonks NK 2002 Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9:387-399
47. Lee SR, Yang KS, Kwon J, Lee C, Jeong W, Rhee SG 2002 Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem 277:20336-20342
48. Leslie NR, Bennett D, Lindsay YE, Stewart H, Gray A, Downes CP 2003 Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J 22:5501-5510
49. Seo JH, Ahn Y, Lee SR, Yeol Yeo C, Chung Hur K 2005 The major target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase/Akt pathway. Mol Biol Cell 16:348-357
50. Schiffrin EL, Touyz RM 2004 From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol 287:H435-H446
51. Kagiyama S, Qian K, Kagiyama T, Phillips MI 2003 Antisense to epidermal growth factor receptor prevents the development of left ventricular hypertrophy. Hypertension 41:824-829
52. Shah BH, Catt KJ 2003 A central role of EGF receptor transactivation in angiotensin II-induced cardiac hypertrophy. Trends Pharmacol Sci 24:239-244
53. Thomas WG, Brandenburger Y, Autelitano DJ, Pham T, Qian H, Hannan RD 2002 Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Circ Res 90:135-142
54. Zhu YC, Zhu YZ, Lu N, Wang MJ, Wang YX, Yao T 2003 Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodelling. Clin Exp Pharmacol Physiol 30:911-918
55. Weiss D, Sorescu D, Taylor WR 2001 Angiotensin II and atherosclerosis. Am J Cardiol 87:25C-32C